{"hands_on_practices": [{"introduction": "Vitrification protocols are built upon precise recipes for cryoprotectant solutions. While these recipes are often written in terms of volume-by-volume percentage ($\\%$ v/v) for practical laboratory preparation, the biophysical effects on the oocyte—such as osmotic shifts and chemical toxicity—are fundamentally dependent on molar concentrations. This exercise provides essential practice in converting between these units, a foundational skill for validating protocols, conducting research, and accurately modeling the cryopreservation process [@problem_id:4478978].", "problem": "A clinical embryology laboratory uses a vitrification medium for oocyte and embryo cryopreservation composed of ethylene glycol (EG) and dimethyl sulfoxide (DMSO) at volume fractions of $15\\%$ v/v each, with the remainder being an aqueous carrier. To parameterize a biophysical toxicity model, the laboratory needs the molarity of each permeating cryoprotectant in the final solution. Starting from the core definitions that (i) molarity is moles of solute per liter of solution, (ii) volume fraction is the solute volume divided by the total solution volume, and (iii) mass equals density times volume, derive the molarity of ethylene glycol and dimethyl sulfoxide under the assumption of additive volumes. Assume ethylene glycol has density $\\rho_{\\mathrm{EG}}=1.11\\,\\mathrm{g}\\,\\mathrm{mL}^{-1}$ and molecular weight $M_{\\mathrm{EG}}=62.07\\,\\mathrm{g}\\,\\mathrm{mol}^{-1}$, and dimethyl sulfoxide (DMSO) has density $\\rho_{\\mathrm{DMSO}}=1.095\\,\\mathrm{g}\\,\\mathrm{mL}^{-1}$ and molecular weight $M_{\\mathrm{DMSO}}=78.13\\,\\mathrm{g}\\,\\mathrm{mol}^{-1}$. Treat the $15\\%$ v/v statements as exact volume fractions and neglect volume changes upon mixing (additive volumes). Express each molarity in $\\mathrm{mol}\\,\\mathrm{L}^{-1}$ and round your final values to four significant figures. Provide your final numerical result as a row vector $\\left(c_{\\mathrm{EG}},\\,c_{\\mathrm{DMSO}}\\right)$, where $c_{\\mathrm{EG}}$ is the molarity of ethylene glycol and $c_{\\mathrm{DMSO}}$ is the molarity of dimethyl sulfoxide.", "solution": "The problem requires the calculation of the molarity of ethylene glycol (EG) and dimethyl sulfoxide (DMSO) in a vitrification medium. The solution is based on the fundamental definitions of molarity, volume fraction, and density, under the explicit assumption of additive volumes.\n\nLet us denote a generic solute species by the subscript $i$. The givens are:\nVolume fraction of EG, $\\phi_{\\mathrm{EG}} = 15\\% = 0.15$.\nVolume fraction of DMSO, $\\phi_{\\mathrm{DMSO}} = 15\\% = 0.15$.\nDensity of EG, $\\rho_{\\mathrm{EG}} = 1.11\\,\\mathrm{g}\\,\\mathrm{mL}^{-1}$.\nMolecular weight of EG, $M_{\\mathrm{EG}} = 62.07\\,\\mathrm{g}\\,\\mathrm{mol}^{-1}$.\nDensity of DMSO, $\\rho_{\\mathrm{DMSO}} = 1.095\\,\\mathrm{g}\\,\\mathrm{mL}^{-1}$.\nMolecular weight of DMSO, $M_{\\mathrm{DMSO}} = 78.13\\,\\mathrm{g}\\,\\mathrm{mol}^{-1}$.\n\nThe molarity, $c_i$, of a solute $i$ is defined as the number of moles of the solute, $n_i$, per unit volume of the total solution, $V_{\\mathrm{sol}}$.\n$$c_i = \\frac{n_i}{V_{\\mathrm{sol}}}$$\n\nThe number of moles, $n_i$, is the mass of the solute, $m_i$, divided by its molar mass or molecular weight, $M_i$.\n$$n_i = \\frac{m_i}{M_i}$$\n\nThe mass of the solute, $m_i$, can be expressed as the product of its density, $\\rho_i$, and its own volume, $V_i$.\n$$m_i = \\rho_i V_i$$\n\nBy substituting the expressions for $n_i$ and $m_i$ into the definition of molarity, we obtain:\n$$c_i = \\frac{\\left(\\frac{\\rho_i V_i}{M_i}\\right)}{V_{\\mathrm{sol}}} = \\frac{\\rho_i V_i}{M_i V_{\\mathrm{sol}}}$$\n\nThe volume fraction of the solute, $\\phi_i$, is defined as the ratio of the solute's volume to the total solution volume.\n$$\\phi_i = \\frac{V_i}{V_{\\mathrm{sol}}}$$\nThis definition is directly applicable here due to the explicit assumption of additive volumes, which implies that the total volume of the solution is the sum of the volumes of its components, and the volume of each component remains unchanged upon mixing.\n\nSubstituting the definition of volume fraction into the expression for molarity yields a general formula for calculating molarity from density, volume fraction, and molecular weight:\n$$c_i = \\frac{\\rho_i \\phi_i}{M_i}$$\n\nWe must now ensure unit consistency. The densities are provided in $\\mathrm{g}\\,\\mathrm{mL}^{-1}$, and the molecular weights in $\\mathrm{g}\\,\\mathrm{mol}^{-1}$. The volume fraction $\\phi_i$ is dimensionless. The resulting unit for molarity $c_i$ is:\n$$\\text{Units of } c_i = \\frac{\\mathrm{g}\\,\\mathrm{mL}^{-1}}{\\mathrm{g}\\,\\mathrm{mol}^{-1}} = \\mathrm{mol}\\,\\mathrm{mL}^{-1}$$\nThe problem requires the molarity to be expressed in $\\mathrm{mol}\\,\\mathrm{L}^{-1}$. Since $1\\,\\mathrm{L} = 1000\\,\\mathrm{mL}$, we must multiply the result by a conversion factor of $1000\\,\\mathrm{mL}\\,\\mathrm{L}^{-1}$.\n$$c_i \\,[\\mathrm{mol}\\,\\mathrm{L}^{-1}] = \\frac{\\rho_i \\phi_i}{M_i} \\times 1000$$\n\nNow we apply this formula to each cryoprotectant.\n\nFor ethylene glycol (EG):\n$$c_{\\mathrm{EG}} = \\frac{\\rho_{\\mathrm{EG}} \\phi_{\\mathrm{EG}}}{M_{\\mathrm{EG}}} \\times 1000$$\nSubstituting the given values:\n$$c_{\\mathrm{EG}} = \\frac{(1.11\\,\\mathrm{g}\\,\\mathrm{mL}^{-1}) \\times 0.15}{62.07\\,\\mathrm{g}\\,\\mathrm{mol}^{-1}} \\times 1000\\,\\mathrm{mL}\\,\\mathrm{L}^{-1}$$\n$$c_{\\mathrm{EG}} = \\frac{0.1665}{62.07} \\times 1000\\,\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\n$$c_{\\mathrm{EG}} \\approx 2.68245529...\\,\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\nRounding to four significant figures, we get $c_{\\mathrm{EG}} = 2.682\\,\\mathrm{mol}\\,\\mathrm{L}^{-1}$.\n\nFor dimethyl sulfoxide (DMSO):\n$$c_{\\mathrm{DMSO}} = \\frac{\\rho_{\\mathrm{DMSO}} \\phi_{\\mathrm{DMSO}}}{M_{\\mathrm{DMSO}}} \\times 1000$$\nSubstituting the given values:\n$$c_{\\mathrm{DMSO}} = \\frac{(1.095\\,\\mathrm{g}\\,\\mathrm{mL}^{-1}) \\times 0.15}{78.13\\,\\mathrm{g}\\,\\mathrm{mol}^{-1}} \\times 1000\\,\\mathrm{mL}\\,\\mathrm{L}^{-1}$$\n$$c_{\\mathrm{DMSO}} = \\frac{0.16425}{78.13} \\times 1000\\,\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\n$$c_{\\mathrm{DMSO}} \\approx 2.10226545...\\,\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\nRounding to four significant figures, we get $c_{\\mathrm{DMSO}} = 2.102\\,\\mathrm{mol}\\,\\mathrm{L}^{-1}$.\n\nThe final result is the ordered pair of molarities $(c_{\\mathrm{EG}},\\,c_{\\mathrm{DMSO}})$.", "answer": "$$\\boxed{\\begin{pmatrix} 2.682 & 2.102 \\end{pmatrix}}$$", "id": "4478978"}, {"introduction": "The central goal of vitrification is to cool a biological sample so rapidly that water molecules are \"frozen\" in a disordered, glass-like state, bypassing the formation of damaging ice crystals. This process is effectively a race against time, governed by the principle of the Critical Cooling Rate (CCR)—the minimum speed required to outrun the physics of ice nucleation. This problem challenges you to quantify the adequacy of a given cooling protocol by developing a safety factor, providing a clear, quantitative framework for assessing the risk of ice formation [@problem_id:4479034].", "problem": "A cryoprotectant-loaded human oocyte is cooled for vitrification using a device that achieves a constant cooling rate of $1500$ degrees Celsius per minute across the temperature interval where ice nucleation is kinetically most probable. For this solution formulation and cell type, experimental calibration has established a critical cooling rate (CCR) of $3000$ degrees Celsius per minute. In vitrification practice, the CCR is defined as the minimal magnitude of the cooling rate required such that the time spent traversing the nucleation-prone temperature interval is shorter than the characteristic nucleation time, thereby suppressing ice formation.\n\nStarting from the following fundamental bases:\n- The time to traverse a temperature interval of width $\\Delta T$ at a constant cooling rate $R$ is $t_{\\text{exp}}=\\Delta T/R$.\n- By definition of the critical cooling rate $R_{c}$, the exposure time at $R=R_{c}$ equals the characteristic nucleation time in the nucleation-prone interval, that is $t_{\\text{nuc}}=\\Delta T/R_{c}$.\n- Ice formation risk increases monotonically as the exposure time $t_{\\text{exp}}$ exceeds $t_{\\text{nuc}}$, and vitrification is expected when $t_{\\text{exp}}\\le t_{\\text{nuc}}$.\n\nUsing only these bases, construct a dimensionless safety factor $S$ that quantifies the adequacy of the applied cooling relative to the critical requirement and compute its value for the given rates. Interpret qualitatively whether vitrification is expected and whether ice formation risk is elevated, but report only the numerical value of $S$ as your final answer. Round your final numerical answer to three significant figures. Express the final answer as a dimensionless number (no units).", "solution": "The problem statement is evaluated as scientifically grounded, well-posed, and objective, meeting all criteria for validity. The problem can be solved using the provided definitions and principles.\n\nThe objective is to construct a dimensionless safety factor, $S$, to quantify the adequacy of a given cooling protocol for vitrification and to compute its numerical value.\n\nThe fundamental principles provided are:\n1.  The time to traverse a temperature interval of width $\\Delta T$ at a constant cooling rate $R$ is $t_{\\text{exp}} = \\frac{\\Delta T}{R}$.\n2.  The characteristic nucleation time, $t_{\\text{nuc}}$, is defined by the critical cooling rate, $R_c$, as $t_{\\text{nuc}} = \\frac{\\Delta T}{R_c}$.\n3.  Successful vitrification is expected when the experimental exposure time does not exceed the nucleation time, i.e., $t_{\\text{exp}} \\le t_{\\text{nuc}}$.\n\nA safety factor in engineering and physics conventionally quantifies how much a system's capacity exceeds the demands placed upon it. A value greater than or equal to $1$ typically signifies a safe or successful state. In this context, the \"capacity\" is the time available before significant nucleation occurs, $t_{\\text{nuc}}$, and the \"demand\" is the time the system is actually exposed to the critical temperature range, $t_{\\text{exp}}$.\n\nFollowing this convention, we define the safety factor $S$ as the ratio of the characteristic nucleation time to the experimental exposure time:\n$$S = \\frac{t_{\\text{nuc}}}{t_{\\text{exp}}}$$\nWith this definition, the condition for successful vitrification, $t_{\\text{exp}} \\le t_{\\text{nuc}}$, becomes equivalent to the condition $S \\ge 1$. This aligns with the standard interpretation of a safety factor, where $S \\ge 1$ indicates that the protocol is adequate or has a margin of safety, while $S < 1$ indicates failure (in this case, expected ice formation).\n\nTo express $S$ in terms of the given cooling rates, we substitute the provided expressions for $t_{\\text{nuc}}$ and $t_{\\text{exp}}$ into our definition of $S$:\n$$S = \\frac{\\left( \\frac{\\Delta T}{R_c} \\right)}{\\left( \\frac{\\Delta T}{R} \\right)}$$\nThe term $\\Delta T$, representing the width of the nucleation-prone temperature interval, is a common factor in both the numerator and the denominator, and thus cancels out:\n$$S = \\frac{\\Delta T}{R_c} \\cdot \\frac{R}{\\Delta T} = \\frac{R}{R_c}$$\nThis result confirms that the safety factor is a dimensionless quantity given by the ratio of the applied cooling rate, $R$, to the critical cooling rate, $R_c$.\n\nThe problem provides the following numerical values:\n- Applied cooling rate: $R = 1500$ degrees Celsius per minute.\n- Critical cooling rate: $R_c = 3000$ degrees Celsius per minute.\n\nWe substitute these values into the derived expression for $S$:\n$$S = \\frac{1500}{3000} = 0.5$$\nThe problem requires the final answer to be rounded to three significant figures. To express $0.5$ with three significant figures, we write it as $0.500$.\n\nQualitatively, a value of $S = 0.500$ is less than $1$. This indicates that the applied cooling rate is only half of the minimum rate required to suppress ice nucleation. Consequently, vitrification is not expected to be successful, and there is an elevated risk of intracellular ice formation, which is typically lethal to the oocyte. The exposure time in the critical temperature range is twice the characteristic time for nucleation ($t_{\\text{exp}} = t_{\\text{nuc}} / S = 2 t_{\\text{nuc}}$).", "answer": "$$\\boxed{0.500}$$", "id": "4479034"}, {"introduction": "Beyond the laboratory, the success of oocyte cryopreservation is measured by its ability to help patients achieve their reproductive goals. This requires translating a cascade of probabilities—oocyte survival, fertilization, and embryonic development—into a coherent clinical strategy. This practice problem demonstrates how to construct a simple probabilistic model to counsel a patient on the number of oocytes to cryopreserve to reach a target likelihood of a future live birth, a crucial and practical skill in fertility preservation [@problem_id:4479010].", "problem": "A patient aged $35$ years is considering oocyte cryopreservation with the goal of achieving a cumulative probability of at least $0.70$ for one live birth in the future. For modeling, assume the following empirically supported rates per banked mature oocyte under contemporary vitrification and intracytoplasmic sperm injection protocols:\n- The probability that an oocyte survives warming and is successfully fertilized to yield a usable blastocyst is $0.60$.\n- The probability that a resulting blastocyst is euploid is $0.30$.\n\nAdopt the standard counseling approximation that once a euploid embryo is available for transfer, optimized transfer strategies (e.g., repeated single-embryo transfers) make the probability of ultimately achieving one live birth from that euploid embryo sufficiently close to $1$ that, for planning purposes, “forming at least one euploid embryo” can be treated as the effective success criterion. Assume independence across oocytes and model each oocyte as an independent Bernoulli trial with a constant per-oocyte success probability derived from the above chain of events.\n\nUsing only these inputs and first principles of Bernoulli trials and the binomial distribution, determine the smallest integer number of oocytes $n$ that should be banked to achieve a cumulative probability of at least $0.70$ of meeting the success criterion. Report the smallest such integer $n$. If your calculation yields a non-integer, you must round up to the next integer. No physical units are required.", "solution": "The modeling starts by defining a Bernoulli trial per banked oocyte. Let $X_{i}$ indicate success for oocyte $i$, where success is defined as “this oocyte ultimately yields a euploid embryo available for transfer,” and, under the stated approximation, this is equated with achieving one live birth.\n\nBy the multiplication rule for independent stages, the per-oocyte success probability is the product of the stagewise probabilities:\n$$\np \\;=\\; p_{\\text{survive+fertilize}} \\times p_{\\text{euploid}} \\;=\\; 0.60 \\times 0.30 \\;=\\; 0.18.\n$$\nAssuming $n$ independent oocytes, the number of successes $K$ follows a binomial distribution with parameters $(n,p)$:\n$$\nK \\sim \\text{Binomial}(n,p).\n$$\nThe cumulative probability of achieving at least one success (i.e., at least one euploid embryo) is given by the complement of having zero successes:\n$$\n\\mathbb{P}(K \\ge 1) \\;=\\; 1 - \\mathbb{P}(K = 0) \\;=\\; 1 - (1 - p)^{n}.\n$$\nThe target is a cumulative probability of at least $0.70$, so we require\n$$\n1 - (1 - p)^{n} \\;\\ge\\; 0.70.\n$$\nRearranging,\n$$\n(1 - p)^{n} \\;\\le\\; 0.30.\n$$\nTaking natural logarithms on both sides and using that for $0 < 1 - p < 1$, $\\ln(1 - p) < 0$, we obtain\n$$\nn \\,\\ln(1 - p) \\;\\le\\; \\ln(0.30),\n$$\nwhich implies (after dividing by the negative number $\\ln(1 - p)$ and flipping the inequality)\n$$\nn \\;\\ge\\; \\frac{\\ln(0.30)}{\\ln(1 - p)}.\n$$\nSubstitute $p = 0.18$:\n$$\nn \\;\\ge\\; \\frac{\\ln(0.30)}{\\ln(0.82)}.\n$$\nEvaluate the bound numerically to select the minimal integer:\n- $\\ln(0.30)$ is negative and approximately $-1.203972804$.\n- $\\ln(0.82)$ is negative and approximately $-0.198450939$.\nThus,\n$$\n\\frac{\\ln(0.30)}{\\ln(0.82)} \\;\\approx\\; \\frac{-1.203972804}{-0.198450939} \\;\\approx\\; 6.07.\n$$\nBecause $n$ must be an integer and must satisfy the inequality, we round up to the next integer:\n$$\nn \\;=\\; 7.\n$$\nA quick check confirms sufficiency:\n$$\n1 - (1 - 0.18)^{7} \\;=\\; 1 - 0.82^{7} \\;\\approx\\; 1 - 0.24928 \\;=\\; 0.75072 \\;\\ge\\; 0.70,\n$$\nwhile for $n = 6$,\n$$\n1 - 0.82^{6} \\;\\approx\\; 1 - 0.304 \\;=\\; 0.696 \\;<\\; 0.70.\n$$\nTherefore, the smallest integer satisfying the target is $n = 7$.", "answer": "$$\\boxed{7}$$", "id": "4479010"}]}